SIMILAR PATTERNS OF AMINO ACIDS FOR 3HEG_A_BAXA1_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1cm8 PHOSPHORYLATED MAP
KINASE P38-GAMMA

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  33
VAL A  41
ALA A  54
LYS A  56
GLU A  74
ILE A 144
 ANP  A 400 ( 4.9A)
ANP  A 400 (-4.1A)
ANP  A 400 (-3.3A)
ANP  A 400 (-2.9A)
None
None
 1.09A 3hegA-1cm8A:
36.9		 3hegA-1cm8A:
61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1cm8 PHOSPHORYLATED MAP
KINASE P38-GAMMA

(Homo sapiens) 		PF00069
(Pkinase) 		7 VAL A  33
VAL A  41
ALA A  54
LYS A  56
LEU A  78
ILE A  87
ILE A 144
 ANP  A 400 ( 4.9A)
ANP  A 400 (-4.1A)
ANP  A 400 (-3.3A)
ANP  A 400 (-2.9A)
None
ANP  A 400 (-4.9A)
None
 1.14A 3hegA-1cm8A:
36.9		 3hegA-1cm8A:
61.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rk2 RIBOKINASE

(Escherichia
coli) 		PF00294
(PfkB) 		5 VAL A 199
ALA A 208
LEU A 177
LEU A 178
ILE A 184
 None
 0.81A 3hegA-1rk2A:
undetectable		 3hegA-1rk2A:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 603
ALA A 621
LYS A 623
LEU A 644
THR A 670
 STI  A   3 ( 4.6A)
STI  A   3 (-3.5A)
STI  A   3 (-3.7A)
STI  A   3 (-4.4A)
STI  A   3 (-3.2A)
 0.60A 3hegA-1t46A:
20.3		 3hegA-1t46A:
26.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1zws DAP-KINASE RELATED
PROTEIN 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  27
ALA A  40
LYS A  42
GLU A  64
LEU A  68
ILE A  77
 None
 0.85A 3hegA-1zwsA:
15.8		 3hegA-1zwsA:
30.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a2a DEATH-ASSOCIATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  27
ALA A  40
LYS A  42
GLU A  64
LEU A  68
ILE A  77
 None
GOL  A3001 (-3.5A)
None
None
None
GOL  A3001 (-4.8A)
 0.94A 3hegA-2a2aA:
22.1		 3hegA-2a2aA:
28.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ac5 MAP
KINASE-INTERACTING
SERINE/THREONINE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		7 VAL A  89
VAL A  98
ALA A 111
LYS A 113
GLU A 129
LEU A 133
ILE A 201
 None
 1.29A 3hegA-2ac5A:
17.3		 3hegA-2ac5A:
27.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2buj SERINE/THREONINE-PRO
TEIN KINASE 16

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  34
ALA A  47
LYS A  49
GLU A  65
ILE A 139
 STU  A1301 (-4.8A)
STU  A1301 (-3.6A)
STU  A1301 ( 4.0A)
None
None
 0.79A 3hegA-2bujA:
22.0		 3hegA-2bujA:
24.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2f9g MITOGEN-ACTIVATED
PROTEIN KINASE FUS3

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		6 VAL A  27
ALA A  40
LYS A  42
GLU A  59
LEU A  63
MET A  96
 ADP  A 500 (-4.3A)
ADP  A 500 ( 3.7A)
ADP  A 500 (-2.9A)
None
None
None
 1.47A 3hegA-2f9gA:
36.0		 3hegA-2f9gA:
45.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2f9g MITOGEN-ACTIVATED
PROTEIN KINASE FUS3

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 VAL A  27
ALA A  40
LYS A  42
LEU A  63
ILE A  72
 ADP  A 500 (-4.3A)
ADP  A 500 ( 3.7A)
ADP  A 500 (-2.9A)
None
None
 0.74A 3hegA-2f9gA:
36.0		 3hegA-2f9gA:
45.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		5 VAL A  42
ALA A  55
LYS A  57
GLU A  76
LEU A  80
 STU  A 400 ( 4.8A)
STU  A 400 (-3.2A)
STU  A 400 ( 4.5A)
None
None
 0.79A 3hegA-2gcdA:
22.6		 3hegA-2gcdA:
26.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hen EPHRIN TYPE-B
RECEPTOR 2

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		6 ALA A 659
LYS A 661
GLU A 678
ILE A 691
THR A 707
ASP A 772
 ADP  A 400 (-3.2A)
ADP  A 400 (-2.7A)
ADP  A 400 ( 4.9A)
None
ADP  A 400 (-4.7A)
ADP  A 400 ( 4.8A)
 1.39A 3hegA-2henA:
21.0		 3hegA-2henA:
25.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hk5 TYROSINE-PROTEIN
KINASE HCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 259
ALA A 271
LYS A 273
GLU A 288
THR A 316
ILE A 355
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
 0.78A 3hegA-2hk5A:
13.2		 3hegA-2hk5A:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 259
ALA A 271
LYS A 273
LEU A 291
THR A 316
ILE A 355
 None
1N8  A 501 ( 3.4A)
1N8  A 501 ( 3.4A)
None
1N8  A 501 ( 3.3A)
None
 1.18A 3hegA-2og8A:
17.8		 3hegA-2og8A:
26.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 838
ALA A 853
LEU A 879
LEU A 876
ILE A 886
ASP A 982
 MR9  A 301 (-4.6A)
MR9  A 301 (-3.5A)
MR9  A 301 (-4.1A)
MR9  A 301 ( 4.5A)
MR9  A 301 (-4.0A)
MR9  A 301 (-4.2A)
 1.32A 3hegA-2p4iA:
11.6		 3hegA-2p4iA:
25.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 838
ALA A 853
LYS A 855
LEU A 876
ASP A 982
 MR9  A 301 (-4.6A)
MR9  A 301 (-3.5A)
MR9  A 301 ( 4.6A)
MR9  A 301 ( 4.5A)
MR9  A 301 (-4.2A)
 0.76A 3hegA-2p4iA:
11.6		 3hegA-2p4iA:
25.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2phk PHOSPHORYLASE KINASE

(Oryctolagus
cuniculus) 		PF00069
(Pkinase) 		5 VAL A  33
ALA A  46
LYS A  48
LEU A  77
ILE A  87
 ATP  A 381 (-4.1A)
ATP  A 381 (-3.5A)
ATP  A 381 (-3.2A)
None
None
 0.81A 3hegA-2phkA:
21.8		 3hegA-2phkA:
29.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qob EPHRIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 VAL A 627
VAL A 635
ALA A 651
LYS A 653
GLU A 670
ILE A 683
THR A 699
 None
BME  A   1 (-4.9A)
PTR  A 701 ( 4.7A)
None
None
None
None
 0.84A 3hegA-2qobA:
17.7		 3hegA-2qobA:
24.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus musculus) 		PF00069
(Pkinase) 		6 ALA A 449
LYS A 451
GLU A 463
LEU A 467
ILE A 477
THR A 493
 None
 0.90A 3hegA-2qr7A:
2.5		 3hegA-2qr7A:
29.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus musculus) 		PF00069
(Pkinase) 		6 ALA A 449
LYS A 451
GLU A 463
LEU A 467
THR A 493
MET A 496
 None
 1.30A 3hegA-2qr7A:
2.5		 3hegA-2qr7A:
29.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2w4k DEATH-ASSOCIATED
PROTEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  27
ALA A  40
LYS A  42
LEU A  68
ILE A  77
 ADP  A1303 (-4.0A)
ADP  A1303 (-3.5A)
ADP  A1303 (-2.7A)
None
ADP  A1303 ( 4.2A)
 0.69A 3hegA-2w4kA:
22.2		 3hegA-2w4kA:
30.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2wnt RIBOSOMAL PROTEIN S6
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A 445
LYS A 447
GLU A 459
LEU A 463
ILE A 473
THR A 489
 None
 1.01A 3hegA-2wntA:
18.9		 3hegA-2wntA:
30.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtk SERINE/THREONINE-PRO
TEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA C  76
LYS C  78
GLU C  98
LEU C 195
LEU C 102
ILE C 111
 ANP  C   2 (-3.4A)
ANP  C   2 (-3.6A)
None
None
None
None
 1.25A 3hegA-2wtkC:
21.6		 3hegA-2wtkC:
28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtk SERINE/THREONINE-PRO
TEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL C  63
ALA C  76
LYS C  78
GLU C  98
LEU C 102
ILE C 111
 ANP  C   2 (-4.2A)
ANP  C   2 (-3.4A)
ANP  C   2 (-3.6A)
None
None
None
 0.89A 3hegA-2wtkC:
21.6		 3hegA-2wtkC:
28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yab DEATH-ASSOCIATED
PROTEIN KINASE 2

(Mus musculus) 		PF00069
(Pkinase) 		5 VAL A  27
ALA A  40
LYS A  42
LEU A  68
ILE A  77
 AMP  A1302 (-4.2A)
AMP  A1302 (-3.6A)
AMP  A1302 (-2.8A)
None
AMP  A1302 ( 3.8A)
 0.74A 3hegA-2yabA:
22.1		 3hegA-2yabA:
27.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zv7 TYROSINE-PROTEIN
KINASE LYN

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		5 VAL A 261
ALA A 273
LYS A 275
THR A 319
ILE A 358
 None
 0.78A 3hegA-2zv7A:
20.7		 3hegA-2zv7A:
26.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bqr DEATH-ASSOCIATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  27
ALA A  40
LYS A  42
LEU A  68
ILE A  77
 4RB  A 401 ( 4.4A)
4RB  A 401 (-3.3A)
4RB  A 401 ( 2.8A)
None
4RB  A 401 ( 4.3A)
 0.60A 3hegA-3bqrA:
20.7		 3hegA-3bqrA:
28.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3coi MITOGEN-ACTIVATED
PROTEIN KINASE 13

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  31
VAL A  39
ALA A  52
GLU A  72
LEU A  76
ILE A 141
 None
 0.76A 3hegA-3coiA:
37.5		 3hegA-3coiA:
61.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3coi MITOGEN-ACTIVATED
PROTEIN KINASE 13

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  31
VAL A  39
ALA A  52
LEU A  75
LEU A  76
ILE A 141
 None
 0.71A 3hegA-3coiA:
37.5		 3hegA-3coiA:
61.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3coi MITOGEN-ACTIVATED
PROTEIN KINASE 13

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  31
VAL A  39
ALA A  52
LEU A  76
ILE A  85
ILE A 141
 None
 0.55A 3hegA-3coiA:
37.5		 3hegA-3coiA:
61.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3e7o MITOGEN-ACTIVATED
PROTEIN KINASE 9

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  40
ALA A  53
LYS A  55
LEU A  77
ILE A  86
 35F  A   1 ( 4.8A)
35F  A   1 (-3.6A)
35F  A   1 ( 4.6A)
None
None
 0.68A 3hegA-3e7oA:
34.3		 3hegA-3e7oA:
50.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f2a PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE PIM-1

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  52
ALA A  65
LYS A  67
LEU A  93
ILE A 104
 985  A   1 (-4.5A)
985  A   1 (-3.5A)
985  A   1 ( 2.8A)
MG  A 314 ( 4.8A)
985  A   1 ( 4.7A)
 0.71A 3hegA-3f2aA:
20.4		 3hegA-3f2aA:
24.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  51
GLU A  71
LEU A  75
THR A 106
ILE A 141
ASP A 168
 NIL  A   1 (-3.7A)
NIL  A   1 (-3.7A)
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.6A)
 0.73A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  51
LEU A  74
LEU A  75
THR A 106
ILE A 141
ASP A 168
 NIL  A   1 (-3.7A)
None
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.6A)
 0.75A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  51
LEU A  75
ILE A  84
THR A 106
ILE A 141
ASP A 168
 NIL  A   1 (-3.7A)
NIL  A   1 ( 4.8A)
NIL  A   1 (-4.4A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.6A)
 0.71A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  51
LYS A  53
GLU A  71
THR A 106
ILE A 141
ASP A 168
 NIL  A   1 (-3.7A)
None
NIL  A   1 (-3.7A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.6A)
 1.06A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 ALA A  51
LYS A  53
ILE A  84
THR A 106
ILE A 141
ASP A 168
 NIL  A   1 (-3.7A)
None
NIL  A   1 (-4.4A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.6A)
 1.08A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  30
VAL A  38
ALA A  51
GLU A  71
LEU A  75
THR A 106
 None
NIL  A   1 ( 4.7A)
NIL  A   1 (-3.7A)
NIL  A   1 (-3.7A)
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
 0.84A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  30
VAL A  38
ALA A  51
LEU A  74
LEU A  75
THR A 106
 None
NIL  A   1 ( 4.7A)
NIL  A   1 (-3.7A)
None
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
 0.66A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  38
ALA A  51
GLU A  71
LEU A  75
THR A 106
ILE A 141
 NIL  A   1 ( 4.7A)
NIL  A   1 (-3.7A)
NIL  A   1 (-3.7A)
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
None
 0.94A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  38
ALA A  51
LEU A  74
LEU A  75
THR A 106
ILE A 141
 NIL  A   1 ( 4.7A)
NIL  A   1 (-3.7A)
None
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
None
 0.91A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  38
ALA A  51
LEU A  75
ILE A  84
THR A 106
ILE A 141
 NIL  A   1 ( 4.7A)
NIL  A   1 (-3.7A)
NIL  A   1 ( 4.8A)
NIL  A   1 (-4.4A)
NIL  A   1 (-3.3A)
None
 0.95A 3hegA-3gp0A:
42.4		 3hegA-3gp0A:
75.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kul EPHRIN TYPE-A
RECEPTOR 8

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM) 		5 VAL A 649
ALA A 665
LYS A 667
ILE A 697
THR A 713
 None
 0.75A 3hegA-3kulA:
21.2		 3hegA-3kulA:
25.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lj0 SERINE/THREONINE-PRO
TEIN
KINASE/ENDORIBONUCLE
ASE IRE1

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A) 		5 VAL A 689
ALA A 700
LYS A 702
LEU A 719
ILE A 729
 ADP  A2101 (-4.5A)
ADP  A2101 (-3.5A)
ADP  A2101 (-2.7A)
None
None
 0.75A 3hegA-3lj0A:
19.8		 3hegA-3lj0A:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3my0 SERINE/THREONINE-PRO
TEIN KINASE RECEPTOR
R3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 208
VAL A 216
ALA A 227
LYS A 229
GLU A 242
THR A 277
 LDN  A 600 ( 4.4A)
LDN  A 600 (-4.5A)
LDN  A 600 (-3.2A)
LDN  A 600 (-4.0A)
None
LDN  A 600 (-4.0A)
 0.93A 3hegA-3my0A:
16.1		 3hegA-3my0A:
26.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3n9x PHOSPHOTRANSFERASE

(Plasmodium
berghei) 		PF00069
(Pkinase) 		5 VAL A  42
ALA A  55
LYS A  57
GLU A  75
ILE A 145
 None
GOL  A 434 ( 4.1A)
GOL  A 433 (-3.2A)
GOL  A 433 ( 4.8A)
None
 0.80A 3hegA-3n9xA:
17.6		 3hegA-3n9xA:
32.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3nie MAP2 KINASE

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		5 VAL A  44
ALA A  57
LYS A  59
LEU A  81
ILE A  90
 ANP  A 430 (-4.2A)
ANP  A 430 (-3.5A)
ANP  A 430 (-2.5A)
None
ANP  A 430 ( 4.5A)
 0.75A 3hegA-3nieA:
33.7		 3hegA-3nieA:
33.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3niz RHODANESE FAMILY
PROTEIN

(Cryptosporidium
parvum) 		PF00069
(Pkinase) 		7 VAL A  29
VAL A  37
ALA A  49
LYS A  51
GLU A  69
LEU A  73
MET A 101
 None
ADP  A 314 (-4.0A)
ADP  A 314 (-3.5A)
ADP  A 314 (-2.8A)
None
None
None
 1.38A 3hegA-3nizA:
27.8		 3hegA-3nizA:
34.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		6 VAL A  31
VAL A  39
ALA A  52
LEU A 152
ILE A  85
THR A 107
 1N1  A1000 ( 4.3A)
1N1  A1000 (-4.6A)
1N1  A1000 (-3.7A)
None
1N1  A1000 ( 4.1A)
1N1  A1000 (-3.3A)
 1.48A 3hegA-3ohtA:
18.6		 3hegA-3ohtA:
87.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		8 VAL A  31
VAL A  39
ALA A  52
LYS A  54
GLU A  72
LEU A  75
LEU A  76
THR A 107
 1N1  A1000 ( 4.3A)
1N1  A1000 (-4.6A)
1N1  A1000 (-3.7A)
1N1  A1000 (-4.5A)
1N1  A1000 (-4.2A)
None
1N1  A1000 (-4.7A)
1N1  A1000 (-3.3A)
 0.77A 3hegA-3ohtA:
18.6		 3hegA-3ohtA:
87.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		9 VAL A  31
VAL A  39
ALA A  52
LYS A  54
LEU A  75
LEU A  76
ILE A  85
THR A 107
ILE A 142
 1N1  A1000 ( 4.3A)
1N1  A1000 (-4.6A)
1N1  A1000 (-3.7A)
1N1  A1000 (-4.5A)
None
1N1  A1000 (-4.7A)
1N1  A1000 ( 4.1A)
1N1  A1000 (-3.3A)
None
 0.68A 3hegA-3ohtA:
18.6		 3hegA-3ohtA:
87.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		7 VAL A  31
VAL A  39
ALA A  52
LYS A  54
LEU A  76
THR A 107
ILE A 147
 1N1  A1000 ( 4.3A)
1N1  A1000 (-4.6A)
1N1  A1000 (-3.7A)
1N1  A1000 (-4.5A)
1N1  A1000 (-4.7A)
1N1  A1000 (-3.3A)
None
 1.33A 3hegA-3ohtA:
18.6		 3hegA-3ohtA:
87.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		6 VAL A  39
LYS A  54
GLU A  72
LEU A  76
THR A 107
ASP A 151
 1N1  A1000 (-4.6A)
1N1  A1000 (-4.5A)
1N1  A1000 (-4.2A)
1N1  A1000 (-4.7A)
1N1  A1000 (-3.3A)
None
 1.44A 3hegA-3ohtA:
18.6		 3hegA-3ohtA:
87.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3omv RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 363
ALA A 373
LYS A 375
GLU A 393
LEU A 397
THR A 421
 SM5  A   1 (-4.0A)
SM5  A   1 (-3.6A)
SM5  A   1 (-3.5A)
SM5  A   1 (-4.3A)
None
SM5  A   1 (-4.4A)
 0.59A 3hegA-3omvA:
20.2		 3hegA-3omvA:
27.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pg1 MITOGEN-ACTIVATED
PROTEIN KINASE,
PUTATIVE (MAP
KINASE-LIKE PROTEIN)

(Leishmania
major) 		PF00069
(Pkinase) 		5 VAL A  37
ALA A  49
LYS A  51
LEU A  82
THR A 112
 None
 0.59A 3hegA-3pg1A:
33.2		 3hegA-3pg1A:
37.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q5i PROTEIN KINASE

(Plasmodium
berghei) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		7 VAL A  71
ALA A  84
LYS A  86
GLU A 115
LEU A 119
ILE A 128
THR A 144
 ANP  A1634 (-4.1A)
ANP  A1634 (-3.6A)
ANP  A1634 (-3.1A)
None
None
None
ANP  A1634 (-4.6A)
 0.94A 3hegA-3q5iA:
12.8		 3hegA-3q5iA:
25.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3txo PROTEIN KINASE C ETA
TYPE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 VAL A 369
ALA A 382
LYS A 384
GLU A 403
LEU A 407
 07U  A   1 (-4.8A)
07U  A   1 (-3.3A)
07U  A   1 (-3.0A)
07U  A   1 ( 4.8A)
None
 0.75A 3hegA-3txoA:
14.9		 3hegA-3txoA:
27.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3zdu CYCLIN-DEPENDENT
KINASE-LIKE 3

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  10
VAL A  18
ALA A  31
LYS A  33
GLU A  50
LEU A  54
 38R  A 350 (-4.4A)
38R  A 350 ( 4.8A)
38R  A 350 (-3.4A)
38R  A 350 (-2.9A)
38R  A 350 ( 4.8A)
None
 0.87A 3hegA-3zduA:
25.3		 3hegA-3zduA:
33.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zfx EPHRIN TYPE-B
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 633
ALA A 649
LYS A 651
GLU A 668
ILE A 681
THR A 697
 None
 0.84A 3hegA-3zfxA:
21.0		 3hegA-3zfxA:
24.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4b99 MITOGEN-ACTIVATED
PROTEIN KINASE 7

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  69
ALA A  82
LYS A  84
GLU A 102
LEU A 106
ILE A 115
 R4L  A1394 (-4.0A)
R4L  A1394 ( 3.7A)
None
None
None
R4L  A1394 (-4.9A)
 0.85A 3hegA-4b99A:
36.5		 3hegA-4b99A:
41.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c02 ACTIVIN RECEPTOR
TYPE-1

(Homo sapiens) 		PF00069
(Pkinase)
PF08515
(TGF_beta_GS) 		6 VAL A 214
VAL A 222
ALA A 233
LYS A 235
GLU A 248
THR A 283
 TAK  A1507 ( 4.3A)
TAK  A1507 (-4.7A)
TAK  A1507 (-3.3A)
TAK  A1507 ( 4.5A)
None
TAK  A1507 (-3.6A)
 0.92A 3hegA-4c02A:
16.6		 3hegA-4c02A:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 624
ALA A 653
LYS A 655
GLU A 672
THR A 701
 DI1  A1000 (-4.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-3.9A)
DI1  A1000 (-3.8A)
DI1  A1000 (-3.6A)
 0.81A 3hegA-4ckrA:
21.5		 3hegA-4ckrA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 624
ALA A 653
LYS A 655
LEU A 679
ILE A 685
THR A 701
 DI1  A1000 (-4.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-3.9A)
DI1  A1000 (-4.5A)
DI1  A1000 (-4.5A)
DI1  A1000 (-3.6A)
 1.14A 3hegA-4ckrA:
21.5		 3hegA-4ckrA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l52 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 7,
TGF-BETA-ACTIVATED
KINASE 1 AND
MAP3K7-BINDING
PROTEIN 1 CHIMERA

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A  42
VAL A  50
ALA A  61
LYS A  63
GLU A  77
LEU A  81
 1UL  A 501 (-4.1A)
1UL  A 501 ( 4.9A)
1UL  A 501 (-3.1A)
None
None
None
 0.89A 3hegA-4l52A:
15.6		 3hegA-4l52A:
27.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mk0 BETA-ADRENERGIC
RECEPTOR KINASE 1

(Homo sapiens) 		PF00069
(Pkinase)
PF00169
(PH)
PF00615
(RGS) 		6 VAL A 205
ALA A 218
LYS A 220
GLU A 239
LEU A 243
MET A 274
 29X  A 702 (-4.7A)
29X  A 702 (-3.1A)
29X  A 702 (-3.6A)
None
None
None
 1.26A 3hegA-4mk0A:
22.4		 3hegA-4mk0A:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4op4 SUCCINYL-DIAMINOPIME
LATE DESUCCINYLASE

(Vibrio cholerae) 		PF01546
(Peptidase_M20) 		6 VAL A 202
ALA A 198
LEU A 191
ILE A 161
THR A 260
ILE A 221
 None
 1.48A 3hegA-4op4A:
undetectable		 3hegA-4op4A:
22.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE

(Leishmania
donovani) 		PF00069
(Pkinase) 		6 VAL A  35
ALA A  49
LYS A  51
LEU A  74
ILE A  83
ILE A 140
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
None
ANP  A 402 (-4.8A)
None
 1.14A 3hegA-4qnyA:
33.5		 3hegA-4qnyA:
38.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qtb MITOGEN-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  56
ALA A  69
LYS A  71
GLU A  88
ILE A 101
ILE A 157
 None
38Z  A 418 (-3.4A)
38Z  A 418 (-2.9A)
38Z  A 418 (-3.4A)
38Z  A 418 ( 4.9A)
None
 1.17A 3hegA-4qtbA:
37.3		 3hegA-4qtbA:
47.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qtb MITOGEN-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  56
ALA A  69
LYS A  71
GLU A  88
LEU A  92
ILE A 101
 None
38Z  A 418 (-3.4A)
38Z  A 418 (-2.9A)
38Z  A 418 (-3.4A)
None
38Z  A 418 ( 4.9A)
 1.12A 3hegA-4qtbA:
37.3		 3hegA-4qtbA:
47.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ra4 PROTEIN KINASE C

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 VAL A 353
ALA A 366
LYS A 368
GLU A 387
LEU A 391
 3KZ  A 701 (-3.9A)
3KZ  A 701 (-3.4A)
3KZ  A 701 ( 4.7A)
None
None
 0.76A 3hegA-4ra4A:
20.1		 3hegA-4ra4A:
27.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tnb G PROTEIN-COUPLED
RECEPTOR KINASE 5

(Homo sapiens) 		PF00069
(Pkinase)
PF00615
(RGS) 		6 VAL A 200
ALA A 213
LYS A 215
GLU A 234
LEU A 238
MET A 266
 SGV  A 601 ( 4.6A)
SGV  A 601 (-3.3A)
SGV  A 601 ( 4.2A)
None
None
None
 1.43A 3hegA-4tnbA:
2.2		 3hegA-4tnbA:
21.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		7 VAL B  30
VAL B  38
ALA B  51
GLU B  71
LEU B  74
LEU B  75
ILE B 141
 None
None
39G  B 401 (-3.5A)
39G  B 401 (-3.4A)
None
39G  B 401 (-4.3A)
None
 0.84A 3hegA-4tyhB:
42.1		 3hegA-4tyhB:
99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		7 VAL B  30
VAL B  38
ALA B  51
LEU B  74
LEU B  75
THR B 106
ILE B 141
 None
None
39G  B 401 (-3.5A)
None
39G  B 401 (-4.3A)
39G  B 401 (-3.6A)
None
 0.69A 3hegA-4tyhB:
42.1		 3hegA-4tyhB:
99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		7 VAL B  30
VAL B  38
ALA B  51
LEU B  75
ILE B  84
THR B 106
ILE B 141
 None
None
39G  B 401 (-3.5A)
39G  B 401 (-4.3A)
39G  B 401 ( 3.8A)
39G  B 401 (-3.6A)
None
 0.57A 3hegA-4tyhB:
42.1		 3hegA-4tyhB:
99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		6 VAL B  38
ALA B  51
LYS B  53
ILE B  84
THR B 106
ILE B 141
 None
39G  B 401 (-3.5A)
39G  B 401 (-4.2A)
39G  B 401 ( 3.8A)
39G  B 401 (-3.6A)
None
 0.84A 3hegA-4tyhB:
42.1		 3hegA-4tyhB:
99.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uvj COHESIN SUBUNIT SCC3

(Saccharomyces
cerevisiae) 		no annotation 6 VAL A 907
ALA A 971
LEU A1030
ILE A 938
ILE A 943
ASP A 936
 None
 1.27A 3hegA-4uvjA:
undetectable		 3hegA-4uvjA:
21.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xrl MITOGEN-ACTIVATED
PROTEIN KINASE 1

(Rattus
norvegicus) 		PF00069
(Pkinase) 		7 VAL A  37
ALA A  50
LYS A  52
GLU A  69
LEU A  73
ILE A  82
ILE A 138
 None
42A  A 402 (-3.2A)
42A  A 402 (-4.1A)
None
None
None
None
 1.16A 3hegA-4xrlA:
36.9		 3hegA-4xrlA:
48.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yff SERINE/THREONINE-PRO
TEIN KINASE TNNI3K

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 477
ALA A 488
LYS A 490
GLU A 509
LEU A 513
THR A 539
 None
4CV  A 801 (-3.5A)
4CV  A 801 (-3.9A)
None
None
4CV  A 801 (-2.8A)
 0.92A 3hegA-4yffA:
12.5		 3hegA-4yffA:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yff SERINE/THREONINE-PRO
TEIN KINASE TNNI3K

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 477
ALA A 488
LYS A 490
LEU A 513
ILE A 522
THR A 539
 None
4CV  A 801 (-3.5A)
4CV  A 801 (-3.9A)
None
4CV  A 801 ( 4.2A)
4CV  A 801 (-2.8A)
 0.78A 3hegA-4yffA:
12.5		 3hegA-4yffA:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yhj G PROTEIN-COUPLED
RECEPTOR KINASE 4

(Homo sapiens) 		PF00069
(Pkinase)
PF00615
(RGS) 		6 VAL A 201
ALA A 214
LYS A 216
GLU A 235
LEU A 239
MET A 267
 AN2  A 601 (-4.0A)
AN2  A 601 (-3.6A)
AN2  A 601 ( 3.9A)
None
None
None
 1.46A 3hegA-4yhjA:
21.5		 3hegA-4yhjA:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ysj CALMODULIN-LIKE
DOMAIN PROTEIN
KINASE

(Eimeria tenella) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		6 VAL A  42
ALA A  55
LYS A  57
GLU A  76
LEU A  80
THR A 105
 ADP  A 506 (-4.3A)
ADP  A 506 (-3.3A)
ADP  A 506 (-2.4A)
None
None
ADP  A 506 ( 4.6A)
 1.04A 3hegA-4ysjA:
22.0		 3hegA-4ysjA:
25.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zsl MITOGEN-ACTIVATED
PROTEIN KINASE 7

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  69
ALA A  82
GLU A 102
LEU A 106
ILE A 115
ASP A 200
 None
None
4QZ  A 401 (-4.3A)
4QZ  A 401 ( 4.7A)
None
None
 1.24A 3hegA-4zslA:
35.7		 3hegA-4zslA:
45.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  31
VAL A  39
ALA A  52
LYS A  54
GLU A  69
LEU A  73
 VAL  A  31 (-0.6A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A  73 ( 0.6A)
 0.72A 3hegA-5d7aA:
21.7		 3hegA-5d7aA:
25.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e8y TGF-BETA RECEPTOR
TYPE-2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 250
ALA A 275
LYS A 277
GLU A 290
THR A 325
 STU  A 601 (-3.9A)
STU  A 601 (-3.1A)
STU  A 601 (-2.4A)
STU  A 601 ( 3.8A)
STU  A 601 ( 3.7A)
 0.80A 3hegA-5e8yA:
19.7		 3hegA-5e8yA:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e8y TGF-BETA RECEPTOR
TYPE-2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 250
VAL A 258
ALA A 275
LYS A 277
THR A 325
 STU  A 601 (-3.9A)
STU  A 601 (-4.0A)
STU  A 601 (-3.1A)
STU  A 601 (-2.4A)
STU  A 601 ( 3.7A)
 0.65A 3hegA-5e8yA:
19.7		 3hegA-5e8yA:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ezr CGMP-DEPENDENT
PROTEIN KINASE,
PUTATIVE

(Plasmodium
vivax) 		PF00027
(cNMP_binding)
PF00069
(Pkinase) 		5 VAL A 548
ALA A 561
LYS A 563
ILE A 595
THR A 611
 4ZS  A 901 (-4.8A)
4ZS  A 901 ( 3.8A)
4ZS  A 901 (-3.9A)
4ZS  A 901 (-4.3A)
4ZS  A 901 (-3.2A)
 0.72A 3hegA-5ezrA:
17.7		 3hegA-5ezrA:
17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gn1 ATP-DEPENDENT
HELICASE FUN30

(Saccharomyces
cerevisiae) 		PF00176
(SNF2_N)
PF00271
(Helicase_C) 		5 LEU A 927
LEU A 924
ILE A 890
ILE A 897
ASP A 915
 None
 0.80A 3hegA-5gn1A:
2.2		 3hegA-5gn1A:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gz8 PROTEIN O-MANNOSE
KINASE

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		5 VAL A  86
VAL A  94
ALA A 105
LEU A 125
THR A 148
 None
 0.64A 3hegA-5gz8A:
11.4		 3hegA-5gz8A:
22.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5idn CYCLIN-DEPENDENT
KINASE 8

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  27
VAL A  35
ALA A  50
LYS A  52
GLU A  66
ILE A  79
 6A7  A 401 (-4.7A)
6A7  A 401 ( 4.5A)
6A7  A 401 (-3.3A)
6A7  A 401 ( 2.9A)
FMT  A 404 ( 4.2A)
6A7  A 401 (-4.2A)
 0.74A 3hegA-5idnA:
20.9		 3hegA-5idnA:
32.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5idn CYCLIN-DEPENDENT
KINASE 8

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  35
ALA A  50
LYS A  52
GLU A  66
LEU A  70
ILE A  79
 6A7  A 401 ( 4.5A)
6A7  A 401 (-3.3A)
6A7  A 401 ( 2.9A)
FMT  A 404 ( 4.2A)
None
6A7  A 401 (-4.2A)
 1.00A 3hegA-5idnA:
20.9		 3hegA-5idnA:
32.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l6o EPHRIN TYPE-B
RECEPTOR 3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 647
ALA A 663
LYS A 665
THR A 711
ASP A 776
 None
6P6  A1001 (-3.3A)
None
6P6  A1001 (-3.5A)
None
 0.72A 3hegA-5l6oA:
21.1		 3hegA-5l6oA:
25.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tur SERINE/THREONINE-PRO
TEIN KINASE PIM-1

(Homo sapiens) 		no annotation 6 VAL A  52
ALA A  65
LYS A  67
GLU A  89
LEU A  93
ILE A 104
 7LK  A 401 (-4.9A)
7LK  A 401 (-3.3A)
None
None
None
7LK  A 401 (-4.8A)
 1.03A 3hegA-5turA:
20.8		 3hegA-5turA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vo1 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 12

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 131
VAL A 139
ALA A 150
LYS A 152
ILE A 174
 None
9FS  A 501 (-4.5A)
9FS  A 501 (-3.4A)
None
None
 0.64A 3hegA-5vo1A:
20.2		 3hegA-5vo1A:
29.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xv7 SERINE-ARGININE (SR)
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 5 VAL A  94
ALA A 107
LYS A 109
GLU A 124
LEU A 128
 EMH  A 705 ( 4.4A)
EMH  A 705 (-3.6A)
EMH  A 705 ( 4.8A)
None
None
 0.70A 3hegA-5xv7A:
24.7		 3hegA-5xv7A:
14.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xvu CASEIN KINASE 2,
ALPHA SUBUNIT

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		5 VAL A  57
ALA A  70
LYS A  72
LEU A  89
ILE A  99
 ATP  A 403 (-3.9A)
ATP  A 403 (-3.4A)
ATP  A 403 (-3.2A)
None
ATP  A 403 (-4.9A)
 0.72A 3hegA-5xvuA:
25.2		 3hegA-5xvuA:
29.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xzw SERINE/THREONINE-PRO
TEIN KINASE RAD53

(Saccharomyces
cerevisiae) 		no annotation 7 VAL A 204
VAL A 212
ALA A 225
LYS A 227
GLU A 244
LEU A 248
ILE A 310
 None
 0.82A 3hegA-5xzwA:
17.5		 3hegA-5xzwA:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y86 DUAL SPECIFICITY
TYROSINE-PHOSPHORYLA
TION-REGULATED
KINASE 3

(Homo sapiens) 		no annotation 6 VAL A 223
ALA A 236
LYS A 238
GLU A 253
LEU A 257
ILE A 272
 HRM  A 601 ( 4.9A)
HRM  A 601 (-3.5A)
HRM  A 601 (-3.3A)
HRM  A 601 ( 4.6A)
None
HRM  A 601 ( 4.8A)
 1.03A 3hegA-5y86A:
24.3		 3hegA-5y86A:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yk2 PROBABLE CONSERVED
ATP-BINDING PROTEIN
ABC TRANSPORTER

(Mycobacterium
tuberculosis) 		no annotation 5 VAL A 135
VAL A 143
ALA A 155
LYS A 157
GLU A 210
 None
 0.72A 3hegA-5yk2A:
6.0		 3hegA-5yk2A:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cnh SERINE/THREONINE-PRO
TEIN KINASE PRP4
HOMOLOG

(Homo sapiens) 		no annotation 6 VAL A 701
ALA A 715
LYS A 717
GLU A 732
LEU A 736
ASP A 834
 919  A1101 (-4.7A)
919  A1101 (-3.5A)
SO4  A1102 ( 2.8A)
919  A1101 (-3.7A)
None
919  A1101 (-4.5A)
 0.93A 3hegA-6cnhA:
26.2		 3hegA-6cnhA:
13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2

(Homo sapiens) 		no annotation 5 VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
 0.81A 3hegA-6fylA:
24.7		 3hegA-6fylA:
undetectable